Therefore, mutations in APP and/or enzyme responsible for APP processing are associated with changes in the level and identity of the amyloid-β products, which may be an important factor in the early onset of Alzheimer’s disease. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.